Eagle Health Investments LP's Q2 2023 13F: 5 new positions, 5 exits
Form 13F-HR for the quarter ended Jun 30, 2023 · filed Aug 14, 2023 · 27 reported positions · accession 0001172661-23-003066
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | DANAHER CORPORATION (DHR) | — | 7.7% | +7.7 pts | +172K sh | new |
| Exited | SEAGEN INC (SGEN) | 6.9% | — | −6.9 pts | −175K sh | −100% |
| New | CATALENT INC (CTLT) | — | 3.7% | +3.7 pts | +460K sh | new |
| New | TRANSMEDICS GROUP INC (TMDX) | — | 3.6% | +3.6 pts | +232K sh | new |
| Reduced | INTUITIVE SURGICAL INC (ISRG) | 7.1% | 5.6% | −1.5 pts | −55,800 sh | −39% |
| Reduced | INSPIRE MED SYS INC (INSP) | 4.6% | 4.4% | −0.2 pts | −28,700 sh | −28% |
| Reduced | NATERA INC (NTRA) | 8.5% | 5.4% | −3.1 pts | −189K sh | −24% |
| Reduced | DEXCOM INC (DXCM) | 5.2% | 3.9% | −1.3 pts | −69,200 sh | −30% |
| Increased | UNITED THERAPEUTICS CORP DEL (UTHR) | 5.7% | 7.1% | +1.3 pts | +39,600 sh | +30% |
| Reduced | ILLUMINA INC (ILMN) | 9.4% | 5.8% | −3.6 pts | −42,172 sh | −20% |
| Increased | ICON PLC (ICLR) | 6.5% | 8.7% | +2.2 pts | +30,300 sh | +19% |
| Reduced | GUARDANT HEALTH INC (GH) | 2.7% | 3.0% | +0.3 pts | −151K sh | −25% |
| Reduced | SAREPTA THERAPEUTICS INC (SRPT) | 3.7% | 2.1% | −1.6 pts | −41,300 sh | −30% |
| New | FUSION PHARMACEUTICALS INC (FUSN) | — | 0.6% | +0.6 pts | +680K sh | new |
| New | POINT BIOPHARMA GLOBAL INC (PNT) | — | 0.5% | +0.5 pts | +306K sh | new |
| Reduced | LANTHEUS HLDGS INC (LNTH) | 4.6% | 4.0% | −0.6 pts | −31,600 sh | −11% |
| Reduced | TANDEM DIABETES CARE INC (TNDM) | 3.4% | 1.5% | −1.9 pts | −105K sh | −25% |
| Increased | PROCEPT BIOROBOTICS CORP (PRCT) | 1.6% | 2.2% | +0.7 pts | +53,000 sh | +19% |
| Reduced | IQVIA HLDGS INC (IQV) | 8.8% | 9.2% | +0.5 pts | −7,000 sh | −3% |
| Exited | OLINK HLDG AB (OLK) | 0.2% | — | −0.2 pts | −40,000 sh | −100% |
| Exited | BEAM THERAPEUTICS INC (BEAM) | 0.2% | — | −0.2 pts | −28,900 sh | −100% |
| Exited | BICYCLE THERAPEUTICS PLC (BCYC) | 0.1% | — | −0.1 pts | −23,500 sh | −100% |
| Exited | LYELL IMMUNOPHARMA INC (LYELXXXX) | 0.0% | — | 0.0 pts | −100K sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 64.0% of the equity book
Changes in the top 10 this quarter: DHR entered · OM entered · SGEN left · DXCM left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | IQVIA HLDGS INC (IQV) | 8.8% | 9.2% | |
| 2 | ICON PLC (ICLR) | 6.5% | 8.7% | |
| 3 | DANAHER CORPORATION (DHR) | 0.0% | 7.7% | Entered the top 10 |
| 4 | UNITED THERAPEUTICS CORP DEL (UTHR) | 5.7% | 7.1% | |
| 5 | ILLUMINA INC (ILMN) | 9.4% | 5.8% | |
| 6 | INTUITIVE SURGICAL INC (ISRG) | 7.1% | 5.6% | |
| 7 | NATERA INC (NTRA) | 8.5% | 5.4% | |
| 8 | OUTSET MED INC (OM) | 4.3% | 4.9% | Entered the top 10 |
| 9 | ALNYLAM PHARMACEUTICALS INC (ALNY) | 5.3% | 4.9% | |
| 10 | ARGENX SE (ARGX) | 4.7% | 4.7% | |
| — | SEAGEN INC (SGEN) | 6.9% | 0.0% | Left the top 10 |
| — | DEXCOM INC (DXCM) | 5.2% | 3.9% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).